Strong Balance SheetHigh equity ratio and low leverage provide durable financial flexibility, reducing refinancing risk and supporting capital allocation for R&D or clinical programs. A 13.75% ROE indicates efficient use of shareholder capital to generate returns, aiding long-term resilience.

Healthy Profitability MarginsConsistently strong gross and operating margins signal structural cost efficiency and pricing power in the business model. Sustained double-digit EBIT/EBITDA margins enable reinvestment and buffer profitability through industry cyclicality, supporting durable operating cash generation.

Solid Operating Cash ConversionOperating cash flow exceeding net income and positive free cash flow growth show improving cash conversion capacity. This enhances the company's ability to fund operations and investment internally over time and lowers dependence on external financing.

Bears Say

Low Free Cash Flow ConversionA 0.04 FCF-to-net-income ratio means most reported profits are not yet translating into discretionary cash. That limits sustainable investment, dividends, or bolt-on M&A capacity and makes long-term funding of growth more dependent on improving cash conversion.

Earnings Volatility / EPS DeclineA sharp negative EPS growth rate signals earnings volatility that undermines predictability for reinvestment and shareholder returns. Structural or operational swings that depress EPS make long-term planning harder and can constrain management's ability to consistently fund strategic priorities.

Inconsistent Revenue TrendA negative revenue-growth metric at the fundamentals level suggests inconsistent top-line performance despite recent year improvement. Persistent revenue variability complicates capacity planning, R&D prioritization, and long-term margin sustainability, increasing execution risk.

177A FAQ

What was Kohjin Bio Co.,Ltd.’s price range in the past 12 months?

Kohjin Bio Co.,Ltd. lowest stock price was ¥1161.00 and its highest was ¥2020.00 in the past 12 months.

What is Kohjin Bio Co.,Ltd.’s market cap?

Kohjin Bio Co.,Ltd.’s market cap is ¥6.17B.

When is Kohjin Bio Co.,Ltd.’s upcoming earnings report date?

Kohjin Bio Co.,Ltd.’s upcoming earnings report date is May 20, 2026 which is in 90 days.

How were Kohjin Bio Co.,Ltd.’s earnings last quarter?

Kohjin Bio Co.,Ltd. released its earnings results on Feb 13, 2026. The company reported ¥15.18 earnings per share for the quarter, beating the consensus estimate of N/A by ¥15.18.

Is Kohjin Bio Co.,Ltd. overvalued?

According to Wall Street analysts Kohjin Bio Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kohjin Bio Co.,Ltd. pay dividends?

Kohjin Bio Co.,Ltd. pays a Notavailable dividend of ¥24 which represents an annual dividend yield of 1.62%. See more information on Kohjin Bio Co.,Ltd. dividends here

What is Kohjin Bio Co.,Ltd.’s EPS estimate?

Kohjin Bio Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kohjin Bio Co.,Ltd. have?

Kohjin Bio Co.,Ltd. has 5,111,600 shares outstanding.

What happened to Kohjin Bio Co.,Ltd.’s price movement after its last earnings report?

Kohjin Bio Co.,Ltd. reported an EPS of ¥15.18 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.548%.

Which hedge fund is a major shareholder of Kohjin Bio Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:177A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kohjin Bio Co.,Ltd.

Kohjin Bio Co., Ltd. is a biotechnology company specializing in the development and production of bioactive compounds and fermentation products. The company operates primarily in the health and wellness sectors, focusing on nutritional supplements, functional foods, and pharmaceutical intermediates. Kohjin Bio is known for its innovative approaches to biotechnology, leveraging fermentation technology to create high-quality, bioavailable ingredients that cater to a growing market for health-conscious consumers.